Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: The Osteoporotic Fractures in Men (MrOS) study
ABSTRACT Normal mineral metabolism is critical for skeletal integrity, and recently serum fibroblast growth factor 23 (FGF23) levels were found to be directly related to overall fracture risk in elderly Swedish men. To confirm this association, we performed a prospective case‐cohort study to underst...
Saved in:
Published in: | Journal of bone and mineral research Vol. 28; no. 11; pp. 2325 - 2332 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Wiley Subscription Services, Inc
01-11-2013
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | ABSTRACT
Normal mineral metabolism is critical for skeletal integrity, and recently serum fibroblast growth factor 23 (FGF23) levels were found to be directly related to overall fracture risk in elderly Swedish men. To confirm this association, we performed a prospective case‐cohort study to understand the relation of FGF23 and fracture risk in older white men enrolled in the Osteoporotic Fractures in Men (MrOS) study. In the cohort of 5994 men attending the baseline MrOS examination, we evaluated a subgroup of 387 men with incident nonvertebral fracture including 73 hip fractures and a sample of 1385 men randomly selected from the cohort with baseline mineral and calcium hormone measurements. FGF23 was measured in baseline serum samples by ELISA (Millipore, Billerica, MA, USA). Modified Cox proportional hazards models that account for case‐cohort study design were used to estimate the relative hazards (RH) of fracture in men across quartiles of FGF23. Subjects were also stratified by renal function, and RH per strata was estimated in men with the highest quartile of FGF23 compared with quartiles 3, 2, and 1. Overall, there was no difference in risk of nonspine or hip fracture by baseline FGF23. However, associations differed by strata of eGFRCrCy. Among men with eGFRCrCys <60 mL/min/1.73 m2 (n = 73/313 nonspine fractures), the RH in the highest quartile of FGF23 compared with the rest was 2.02 (95% confidence interval [CI] 1.07–3.79), but in men with eGFRCrCy, >60 mL/min/1.73 m2 (304/1370 fractures) the RH was 0.91 (95% CI 0.66–1.25) after adjustment for age, clinic site, body mass index, race, total hip bone mineral density, vitamin D, parathyroid hormone, alcohol use, physical activity, fracture history, and serum phosphorus. Serum FGF23 levels are not associated with incident fractures in elderly men overall. However, higher levels of serum FGF23 are associated with fracture risk in those with poor renal function. © 2013 American Society for Bone and Mineral Research. |
---|---|
AbstractList | Normal mineral metabolism is critical for skeletal integrity, and recently serum fibroblast growth factor 23 (FGF23) levels were found to be directly related to overall fracture risk in elderly Swedish men. To confirm this association, we performed a prospective case-cohort study to understand the relation of FGF23 and fracture risk in older white men enrolled in the Osteoporotic Fractures in Men (MrOS) study. In the cohort of 5994 men attending the baseline MrOS examination, we evaluated a subgroup of 387 men with incident nonvertebral fracture including 73 hip fractures and a sample of 1385 men randomly selected from the cohort with baseline mineral and calcium hormone measurements. FGF23 was measured in baseline serum samples by ELISA (Millipore, Billerica, MA, USA). Modified Cox proportional hazards models that account for case-cohort study design were used to estimate the relative hazards (RH) of fracture in men across quartiles of FGF23. Subjects were also stratified by renal function, and RH per strata was estimated in men with the highest quartile of FGF23 compared with quartiles 3, 2, and 1. Overall, there was no difference in risk of nonspine or hip fracture by baseline FGF23. However, associations differed by strata of eGFRCrCy . Among men with eGFRCrCys <60 mL/min/1.73 m2 (n = 73/313 nonspine fractures), the RH in the highest quartile of FGF23 compared with the rest was 2.02 (95% confidence interval [CI] 1.07-3.79), but in men with eGFRCrCy , >60 mL/min/1.73 m2 (304/1370 fractures) the RH was 0.91 (95% CI 0.66-1.25) after adjustment for age, clinic site, body mass index, race, total hip bone mineral density, vitamin D, parathyroid hormone, alcohol use, physical activity, fracture history, and serum phosphorus. Serum FGF23 levels are not associated with incident fractures in elderly men overall. However, higher levels of serum FGF23 are associated with fracture risk in those with poor renal function. Normal mineral metabolism is critical for skeletal integrity, and recently serum fibroblast growth factor 23 (FGF23) levels were found to be directly related to overall fracture risk in elderly Swedish men. To confirm this association, we performed a prospective case-cohort study to understand the relation of FGF23 and fracture risk in older white men enrolled in the Osteoporotic Fractures in Men (MrOS) study. In the cohort of 5994 men attending the baseline MrOS examination, we evaluated a subgroup of 387 men with incident nonvertebral fracture including 73 hip fractures and a sample of 1385 men randomly selected from the cohort with baseline mineral and calcium hormone measurements. FGF23 was measured in baseline serum samples by ELISA (Millipore, Billerica, MA, USA). Modified Cox proportional hazards models that account for case-cohort study design were used to estimate the relative hazards (RH) of fracture in men across quartiles of FGF23. Subjects were also stratified by renal function, and RH per strata was estimated in men with the highest quartile of FGF23 compared with quartiles 3, 2, and 1. Overall, there was no difference in risk of nonspine or hip fracture by baseline FGF23. However, associations differed by strata of eGFRCrCy. Among men with eGFRCrCys <60mL/min/1.73m2 (n=73/313 nonspine fractures), the RH in the highest quartile of FGF23 compared with the rest was 2.02 (95% confidence interval [CI] 1.07-3.79), but in men with eGFRCrCy, >60mL/min/1.73m2 (304/1370 fractures) the RH was 0.91 (95% CI 0.66-1.25) after adjustment for age, clinic site, body mass index, race, total hip bone mineral density, vitamin D, parathyroid hormone, alcohol use, physical activity, fracture history, and serum phosphorus. Serum FGF23 levels are not associated with incident fractures in elderly men overall. However, higher levels of serum FGF23 are associated with fracture risk in those with poor renal function. © 2013 American Society for Bone and Mineral Research. [PUBLICATION ABSTRACT] ABSTRACT Normal mineral metabolism is critical for skeletal integrity, and recently serum fibroblast growth factor 23 (FGF23) levels were found to be directly related to overall fracture risk in elderly Swedish men. To confirm this association, we performed a prospective case‐cohort study to understand the relation of FGF23 and fracture risk in older white men enrolled in the Osteoporotic Fractures in Men (MrOS) study. In the cohort of 5994 men attending the baseline MrOS examination, we evaluated a subgroup of 387 men with incident nonvertebral fracture including 73 hip fractures and a sample of 1385 men randomly selected from the cohort with baseline mineral and calcium hormone measurements. FGF23 was measured in baseline serum samples by ELISA (Millipore, Billerica, MA, USA). Modified Cox proportional hazards models that account for case‐cohort study design were used to estimate the relative hazards (RH) of fracture in men across quartiles of FGF23. Subjects were also stratified by renal function, and RH per strata was estimated in men with the highest quartile of FGF23 compared with quartiles 3, 2, and 1. Overall, there was no difference in risk of nonspine or hip fracture by baseline FGF23. However, associations differed by strata of eGFRCrCy. Among men with eGFRCrCys <60 mL/min/1.73 m2 (n = 73/313 nonspine fractures), the RH in the highest quartile of FGF23 compared with the rest was 2.02 (95% confidence interval [CI] 1.07–3.79), but in men with eGFRCrCy, >60 mL/min/1.73 m2 (304/1370 fractures) the RH was 0.91 (95% CI 0.66–1.25) after adjustment for age, clinic site, body mass index, race, total hip bone mineral density, vitamin D, parathyroid hormone, alcohol use, physical activity, fracture history, and serum phosphorus. Serum FGF23 levels are not associated with incident fractures in elderly men overall. However, higher levels of serum FGF23 are associated with fracture risk in those with poor renal function. © 2013 American Society for Bone and Mineral Research. Normal mineral metabolism is critical for skeletal integrity and recently serum fibroblast Growth factor 23 (FGF23) levels were found to be directly related to overall fracture risk in elderly Swedish Men. To confirm this association, we performed a prospective case-cohort study to understand the relation of FGF23 and fracture risk in older Caucasian men enrolled in the Osteoporotic Fractures in Men (MrOS) Study. Normal mineral metabolism is critical for skeletal integrity, and recently serum fibroblast growth factor 23 (FGF23) levels were found to be directly related to overall fracture risk in elderly Swedish men. To confirm this association, we performed a prospective case-cohort study to understand the relation of FGF23 and fracture risk in older white men enrolled in the Osteoporotic Fractures in Men (MrOS) study. In the cohort of 5994 men attending the baseline MrOS examination, we evaluated a subgroup of 387 men with incident nonvertebral fracture including 73 hip fractures and a sample of 1385 men randomly selected from the cohort with baseline mineral and calcium hormone measurements. FGF23 was measured in baseline serum samples by ELISA (Millipore, Billerica, MA, USA). Modified Cox proportional hazards models that account for case-cohort study design were used to estimate the relative hazards (RH) of fracture in men across quartiles of FGF23. Subjects were also stratified by renal function, and RH per strata was estimated in men with the highest quartile of FGF23 compared with quartiles 3, 2, and 1. Overall, there was no difference in risk of nonspine or hip fracture by baseline FGF23. However, associations differed by strata of eGFR sub(CrCy). Among men with eGFR sub(CrCys) < 60mL/min/1.73 m super(2) (n = 73/313 nonspine fractures), the RH in the highest quartile of FGF23 compared with the rest was 2.02 (95% confidence interval [CI] 1.07-3.79), but in men with eGFR sub(CrCy), > 60 mL/min/1.73 m super(2) (304/1370 fractures) the RH was 0.91 (95% CI 0.66-1.25) after adjustment for age, clinic site, body mass index, race, total hip bone mineral density, vitamin D, parathyroid hormone, alcohol use, physical activity, fracture history, and serum phosphorus. Serum FGF23 levels are not associated with incident fractures in elderly men overall. However, higher levels of serum FGF23 are associated with fracture risk in those with poor renal function. |
Author | Lane, Nancy E Orwoll, Eric Kado, Deborah Cauley, Jane A Yao, Wei Corr, Maripat Parimi, Neeta Nielson, Carrie M Ix, Joseph H |
AuthorAffiliation | 1 University of California at Davis, Sacramento 3 University of California, San Diego 5 Oregon Health & Science University, Portland OR 4 University of Pittsburgh, Pittsburgh, PA 2 California Pacific Medical Center Research Institute, San Francisco, CA |
AuthorAffiliation_xml | – name: 3 University of California, San Diego – name: 5 Oregon Health & Science University, Portland OR – name: 1 University of California at Davis, Sacramento – name: 2 California Pacific Medical Center Research Institute, San Francisco, CA – name: 4 University of Pittsburgh, Pittsburgh, PA |
Author_xml | – sequence: 1 givenname: Nancy E surname: Lane fullname: Lane, Nancy E organization: Sacramento – sequence: 2 givenname: Neeta surname: Parimi fullname: Parimi, Neeta organization: San Francisco – sequence: 3 givenname: Maripat surname: Corr fullname: Corr, Maripat organization: San Diego – sequence: 4 givenname: Wei surname: Yao fullname: Yao, Wei organization: Sacramento – sequence: 5 givenname: Jane A surname: Cauley fullname: Cauley, Jane A organization: Pittsburgh – sequence: 6 givenname: Carrie M surname: Nielson fullname: Nielson, Carrie M organization: Portland – sequence: 7 givenname: Joseph H surname: Ix fullname: Ix, Joseph H organization: Portland – sequence: 8 givenname: Deborah surname: Kado fullname: Kado, Deborah organization: San Diego – sequence: 9 givenname: Eric surname: Orwoll fullname: Orwoll, Eric organization: Portland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23677793$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkt9qFDEUh4NU7LZ64QtIwJvdi2nzPxMvhFrcqnRZ0HodMjNJN8tMsiYzln0HH9oZt5YqCN4kkPPxkXPO7wQchRgsAC8xOsMIkfNt1aUzrEr-BMwwJ7RgosRHYIbKkhWIUXwMTnLeIoQEF-IZOCZUSCkVnYEfFznH2pvexwCjg9mmoYPOVylWrck9vE3xrt9AZ-o-JkgonC-vloQuoAkN9KH2jQ09dGmsD8nm8QnGtrEJdja8gTcbC9e5t3EXU-x9DZePwZUNcL5K6y8LmPuh2T8HT51ps31xf5-Cr8v3N5cfiuv11cfLi-ui5ozwouLKYY4bzqghuKnGg2ChiGPOCUGYcYo2kiHDlSKSSudwjSQluLTMcm7oKXh78O6GqrNNPXaQTKt3yXcm7XU0Xv9ZCX6jb-N3TUvESyxHwfxekOK3weZedz7Xtm1NsHHIGjPBOJKciP9AGVVKUTJZX_-FbuOQwjiJiSKS0ZKykVocqDrFnJN1D__GSE9x0FMc9BSHkX31uNEH8vf-R-D8ANz51u7_bdKf3q0-_1L-BAv-wG8 |
CODEN | JBMREJ |
CitedBy_id | crossref_primary_10_1111_nep_12319 crossref_primary_10_1007_s00198_021_06001_6 crossref_primary_10_1177_1759720X15621227 crossref_primary_10_1155_2017_3485785 crossref_primary_10_1002_jbmr_3900 crossref_primary_10_1016_j_rhum_2016_06_006 crossref_primary_10_1016_j_jdiacomp_2019_107476 crossref_primary_10_1080_08977194_2023_2274579 crossref_primary_10_1016_j_exphem_2020_09_190 crossref_primary_10_1186_s12979_017_0097_0 crossref_primary_10_1007_s40291_017_0272_1 crossref_primary_10_3389_fendo_2023_1152464 crossref_primary_10_1016_j_jocd_2014_01_010 crossref_primary_10_1002_jbmr_4443 crossref_primary_10_1002_jbmr_2487 crossref_primary_10_1016_j_medcli_2014_01_008 crossref_primary_10_1002_jbm4_10697 crossref_primary_10_1016_j_bone_2024_117123 crossref_primary_10_1186_s40001_018_0315_z crossref_primary_10_1007_s00198_018_4598_2 crossref_primary_10_1016_j_bone_2021_115885 crossref_primary_10_1016_j_jbspin_2016_09_022 crossref_primary_10_3390_ijms25094875 crossref_primary_10_1007_s00424_014_1625_9 crossref_primary_10_1016_j_bone_2014_05_016 crossref_primary_10_1093_rheumatology_kev410 crossref_primary_10_5604_16652681_1231580 crossref_primary_10_1007_s00198_019_04996_7 crossref_primary_10_1371_journal_pone_0133278 crossref_primary_10_1186_s12882_021_02393_z crossref_primary_10_1016_j_bone_2016_03_005 crossref_primary_10_1007_s40620_017_0410_1 crossref_primary_10_1089_rej_2013_1475 crossref_primary_10_1016_j_bbrc_2015_10_018 crossref_primary_10_1002_jbmr_2750 crossref_primary_10_1210_jc_2016_4038 crossref_primary_10_1016_j_bone_2020_115777 crossref_primary_10_3390_diagnostics10030145 crossref_primary_10_1002_pbc_25188 crossref_primary_10_1016_j_bone_2017_02_005 crossref_primary_10_1111_cen_13981 crossref_primary_10_1210_clinem_dgac071 crossref_primary_10_2215_CJN_07060714 crossref_primary_10_3390_ijms23052500 |
Cites_doi | 10.1002/jbmr.5650110716 10.1359/JBMR.0301264 10.1056/NEJMoa1114248 10.1053/j.ajkd.2007.11.018 10.1152/ajpendo.90201.2008 10.1038/ki.2010.194 10.1359/jbmr.080220 10.1093/biomet/73.1.1 10.1038/ki.2011.47 10.1002/jbmr.263 10.1007/s00467-012-2309-3 10.1002/jor.20857 10.1111/j.1523-1755.2005.00178.x 10.1111/j.1744-9987.2005.00293.x 10.1111/j.1532-5415.2010.03245.x 10.1210/en.2003-1768 10.1074/jbc.C500457200 10.1146/annurev.physiol.69.040705.141729 10.1359/jbmr.2003.18.7.1227 10.1053/j.ajkd.2011.05.019 10.1016/j.cct.2005.05.005 10.1152/ajprenal.00199.2012 10.1002/jbmr.1810 10.1210/jc.2008-2786 10.1093/jmicro/dfp032 10.1016/j.cct.2005.05.006 10.1210/jc.2006-0710 10.1080/00365519950185940 10.1359/jbmr.061017 10.1038/ng1905 |
ContentType | Journal Article |
Copyright | 2013 American Society for Bone and Mineral Research 2013 American Society for Bone and Mineral Research. |
Copyright_xml | – notice: 2013 American Society for Bone and Mineral Research – notice: 2013 American Society for Bone and Mineral Research. |
CorporateAuthor | Osteoporotic Fractures in Men (MrOS) Study Group for the Osteoporotic Fractures in Men (MrOS) Study Group |
CorporateAuthor_xml | – name: Osteoporotic Fractures in Men (MrOS) Study Group – name: for the Osteoporotic Fractures in Men (MrOS) Study Group |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7TS K9. 7X8 5PM |
DOI | 10.1002/jbmr.1985 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts Physical Education Index ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts Physical Education Index MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1523-4681 |
EndPage | 2332 |
ExternalDocumentID | 3102292801 10_1002_jbmr_1985 23677793 JBMR1985 |
Genre | article Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) – fundername: NIH Roadmap for Medical Research funderid: U01 AR45580; U01 AR45614; U01 AR45632; U01 AR45647; U01 AR45654; U01 AR45583; U01 AG18197; U01‐AG027810; UL1 RR024140 – fundername: National Institute on Aging (NIA) – fundername: National Center for Research Resources (NCRR) – fundername: NIAMS NIH HHS grantid: K01 AR062655 – fundername: NIAMS NIH HHS grantid: U01 AR045583 – fundername: NIAMS NIH HHS grantid: U01 AR45583 – fundername: NIAMS NIH HHS grantid: U01 AR045614 – fundername: NIAMS NIH HHS grantid: U01 AR045580 – fundername: NIAMS NIH HHS grantid: U01 AR045632 – fundername: NIAMS NIH HHS grantid: U01 AR45614 – fundername: NIAMS NIH HHS grantid: U01 AR45654 – fundername: NIAMS NIH HHS grantid: U01 AR45647 – fundername: NIAMS NIH HHS grantid: U01 AR045647 – fundername: National Center for Research Resources : NCRR grantid: UL1 RR024140 || RR – fundername: National Institute on Aging : NIA grantid: U01 AG018197 || AG – fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases : NIAMS grantid: U01 AR045614 || AR – fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases : NIAMS grantid: U01 AR045647 || AR – fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases : NIAMS grantid: U01 AR045580 || AR – fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases : NIAMS grantid: U01 AR045632 || AR – fundername: National Institute on Aging : NIA grantid: U01 AG027810 || AG – fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases : NIAMS grantid: U01 AR045583 || AR – fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases : NIAMS grantid: U01 AR045654 || AR – fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases : NIAMS grantid: K24 AR048841 || AR |
GroupedDBID | --- .55 .GJ 05W 0R~ 1OB 1OC 24P 29K 2WC 31~ 33P 3SF 3WU 4.4 50Y 52U 53G 5GY 5RE 5WD 66C 8-0 8-1 A00 AAESR AAEVG AAHHS AANLZ AAONW AAPXW AASGY AAUAY AAXRX AAZKR ABCUV ABEFU ABJNI ABNHQ ABQNK ABXGK ABXVV ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACXBN ACXQS ACZBC ADBTR ADEOM ADIPN ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFGKR AFPWT AFZJQ AGMDO AHMBA AIACR AIURR AIWBW AJAOE AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVNTJ AVWKF AZBYB AZFZN AZVAB BCRHZ BDRZF BFHJK BHBCM BMXJE BNHUX BOGZA BQCPF BRXPI CS3 D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN F5P FEDTE FUBAC G-S GK1 GODZA HVGLF HZ~ IJI IX1 KBYEO LATKE LEEKS LITHE LOXES LUTES LYRES MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ NNB O66 O9- OCZFY OJZSN OK1 OVD OWPYF P2P P2W P4E PALCI PQQKQ R.K RIG RIWAO RJQFR ROL ROX RWI RX1 SJN SUPJJ TEORI TR2 VJK W99 WBKPD WIH WIJ WIK WNSPC WOHZO WYISQ WYJ X7M XV2 ZGI ZXP ZZTAW ~S- CGR CUY CVF ECM EIF NPM AAYXX ABEJV CITATION 7QP 7TS K9. 7X8 5PM |
ID | FETCH-LOGICAL-c5425-b59f151d543a21dba2121692f4ff6624af93d740a5992737ff1c073218e4e55a3 |
IEDL.DBID | 33P |
ISSN | 0884-0431 |
IngestDate | Tue Sep 17 20:56:38 EDT 2024 Fri Oct 25 03:02:50 EDT 2024 Fri Oct 25 02:50:15 EDT 2024 Thu Oct 10 14:26:14 EDT 2024 Thu Nov 21 21:11:04 EST 2024 Sat Sep 28 08:32:18 EDT 2024 Sat Aug 24 00:57:09 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | FGF23 OSTEOPOROSIS MEN |
Language | English |
License | 2013 American Society for Bone and Mineral Research. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5425-b59f151d543a21dba2121692f4ff6624af93d740a5992737ff1c073218e4e55a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jbmr.1985 |
PMID | 23677793 |
PQID | 1442743834 |
PQPubID | 1006376 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3805817 proquest_miscellaneous_1464507526 proquest_miscellaneous_1443999327 proquest_journals_1442743834 crossref_primary_10_1002_jbmr_1985 pubmed_primary_23677793 wiley_primary_10_1002_jbmr_1985_JBMR1985 |
PublicationCentury | 2000 |
PublicationDate | November 2013 |
PublicationDateYYYYMMDD | 2013-11-01 |
PublicationDate_xml | – month: 11 year: 2013 text: November 2013 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Baltimore |
PublicationTitle | Journal of bone and mineral research |
PublicationTitleAlternate | J Bone Miner Res |
PublicationYear | 2013 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2004; 145 2010; 78 2006; 91 2013; 28 1986; 73 2006; 38 2007 1996 2011; 79 2003; 18 2011; 59 2011; 58 2005; 26 2012; 367 2008; 51 2012; 303 2009; 27 2005; 67 2009; 58 2004; 19 2009; 94 2005; 9 1999; 59 2008; 23 2012; 28 2011; 26 2006; 281 2007; 22 2008; 295 2007; 69 Bonewald (2024020318340624200_jbmr1985-bib-0005) 2013; 28 Ubaidus (2024020318340624200_jbmr1985-bib-0024) 2009; 58 Wšhrle (2024020318340624200_jbmr1985-bib-0030) 2012; 28 Mirza (2024020318340624200_jbmr1985-bib-0003) 2011; 26 Erlandsen (2024020318340624200_jbmr1985-bib-0014) 1999; 59 Kurosu (2024020318340624200_jbmr1985-bib-0027) 2006; 281 Shimada (2024020318340624200_jbmr1985-bib-0002) 2004; 19 Stevens (2024020318340624200_jbmr1985-bib-0016) 2008; 51 Goebel (2024020318340624200_jbmr1985-bib-0028) 2009; 27 Inker (2024020318340624200_jbmr1985-bib-0017) 2012; 367 Krieger (2024020318340624200_jbmr1985-bib-0029) 2012; 303 Singh (2024020318340624200_jbmr1985-bib-0013) 2006; 91 Isakova (2024020318340624200_jbmr1985-bib-0022) 2011; 79 Weber (2024020318340624200_jbmr1985-bib-0018) 2003; 18 Ensrud (2024020318340624200_jbmr1985-bib-0020) 2009; 94 Berndt (2024020318340624200_jbmr1985-bib-0001) 2007; 69 Wang (2024020318340624200_jbmr1985-bib-0023) 2008; 23 Koiwa (2024020318340624200_jbmr1985-bib-0032) 2005; 9 Blank (2024020318340624200_jbmr1985-bib-0009) 2005; 26 Larsson (2024020318340624200_jbmr1985-bib-0007) 2004; 145 Orwoll (2024020318340624200_jbmr1985-bib-0008) 2005; 26 Lewis (2024020318340624200_jbmr1985-bib-0011) 2007; 22 Genant (2024020318340624200_jbmr1985-bib-0012) 1996 Lee (2024020318340624200_jbmr1985-bib-0021) 2011; 59 Kazama (2024020318340624200_jbmr1985-bib-0031) 2005; 67 Liu (2024020318340624200_jbmr1985-bib-0026) 2008; 295 Inker (2024020318340624200_jbmr1985-bib-0015) 2011; 58 Feng (2024020318340624200_jbmr1985-bib-0004) 2006; 38 Prentice (2024020318340624200_jbmr1985-bib-0010) 1986; 73 Weber (2024020318340624200_jbmr1985-bib-0025) 2003; 18 Bonewald (2024020318340624200_jbmr1985-bib-0006) 2007 Yilmaz (2024020318340624200_jbmr1985-bib-0019) 2010; 78 |
References_xml | – volume: 26 start-page: 569 issue: 5 year: 2005 end-page: 85 article-title: Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study—a large observational study of the determinants of fracture in older men publication-title: Contemp Clin Trials. – volume: 28 start-page: 563 issue: 4 year: 2013 end-page: 8 article-title: FGF23 production by osteocytes publication-title: Pediatr Nephrol. – volume: 79 start-page: 1370 issue: 12 year: 2011 end-page: 8 article-title: Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease publication-title: Kidney Int. – start-page: 984 year: 1996 end-page: 96 article-title: Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis publication-title: J Bone Miner Res. – volume: 145 start-page: 3087 year: 2004 end-page: 94 article-title: Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha I collagen promoter exhibit growth retardation, osteomalacia and disturbed phosphate homeostasis publication-title: Endocrinology. – volume: 38 start-page: 1310 year: 2006 end-page: 5 article-title: Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism publication-title: Nat Genet. – volume: 367 start-page: 20 issue: 1 year: 2012 end-page: 9 article-title: Levey AS; CKD‐EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C publication-title: N Engl J Med. – volume: 26 start-page: 557 issue: 5 year: 2005 end-page: 68 article-title: Overview of recruitment for the osteoporotic fractures in men study (MrOS) publication-title: Contemp Clin Trials. – volume: 58 start-page: 381 issue: 6 year: 2009 end-page: 92 article-title: FGF23 is mainly synthesized by osteocytes in the regularly distributed osteocytic lacunar canalicular system established after physiological bone remodeling publication-title: J Electron Microsc (Tokyo). – volume: 9 start-page: 336 year: 2005 end-page: 9 article-title: Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients publication-title: Ther Apher Dial. – volume: 73 start-page: 1 year: 1986 end-page: 11 article-title: A case‐control design for epidemiologic cohort studies and disease prevention trials publication-title: Biometricka. – volume: 59 start-page: 1 issue: 1 year: 1999 end-page: 8 article-title: Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System publication-title: Scand J Clin Lab Invest. – volume: 23 start-page: 939 issue: 6 year: 2008 end-page: 48 article-title: Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro publication-title: J Bone Miner Res. – volume: 27 start-page: 1141 issue: 9 year: 2009 end-page: 6 article-title: FGF23 is a putative marker for bone healing and regeneration publication-title: J Orthop Res. – start-page: 169 year: 2007 end-page: 90 – volume: 22 start-page: 211 issue: 2 year: 2007 end-page: 9 article-title: Predictors of nonspine fracture in elderly men: the MrOS study publication-title: J Bone Miner Res. – volume: 91 start-page: 3055 issue: 8 year: 2006 end-page: 61 article-title: C‐3 epimers can account for a significant proportion of total circulating 25‐hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status publication-title: J Clin Endocrinol Metab. – volume: 26 start-page: 857 year: 2011 end-page: 64 article-title: Serum fibroblast growth factor‐23 (FFGF‐23) and fracture risk in elderly men publication-title: J Bone Miner Res. – volume: 69 start-page: 341 year: 2007 end-page: 59 article-title: Phosphatonins and the regulation of phosphate homeostasis publication-title: Annu Rev Physiolo. – volume: 59 start-page: 233 year: 2011 end-page: 40 article-title: Mortality risk in older men associated with changes in weight, lean mass, and fat mass publication-title: J Am Geriatr Soc. – volume: 28 start-page: 899 issue: 4 year: 2012 end-page: 911 article-title: Pharmacological inhibition of FGFR signaling ameliorates FGF23‐mediated hypophosphatemic rickets publication-title: J Bone Miner Res. – volume: 51 start-page: 395 year: 2008 end-page: 406 article-title: Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD publication-title: Am J Kidney Dis. – volume: 78 start-page: 679 year: 2010 end-page: 85 article-title: FGF‐23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease publication-title: Kidney Int. – volume: 281 start-page: 6120 issue: 10 year: 2006 end-page: 3 article-title: Regulation of fibroblast growth factor‐23 signaling by klotho publication-title: J Biol Chem. – volume: 295 start-page: E254 issue: 2 year: 2008 end-page: 61 article-title: Pathogenic role of Fgf23 in Dmp1‐null mice publication-title: Am J Physiol Endocrinol Metab. – volume: 58 start-page: 682 year: 2011 end-page: 4 article-title: Expressing the CKD‐EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values publication-title: Am J Kidney Dis. – volume: 94 start-page: 2773 year: 2009 end-page: 80 article-title: Serum 25‐hydroxyvitamin D levels and rate of hip bone loss in older men publication-title: J Clin Endocrinol Metab. – volume: 303 start-page: F431 issue: 3 year: 2012 end-page: 6 article-title: Metabolic acisois increase fibroblast growth factor 23 in neomatula mouse bone publication-title: Am J Physiol Renal Physiol. – volume: 19 start-page: 429 year: 2004 end-page: 35 article-title: FGF‐23 is a potent regulator of vitamin D metabolism and phosphonate homeostasis publication-title: J Bone Miner Res. – volume: 18 start-page: 1227 issue: 7 year: 2003 end-page: 34 article-title: Serum FGF23 levels in normal and disordered phosphorus homeostasis publication-title: J Bone Miner Res. – volume: 67 start-page: 1120 year: 2005 end-page: 5 article-title: Pretreatment serum FGF‐23 levels predict the efficacy of calcitriol therapy in dialysis patients publication-title: Kidney Int. – start-page: 984 year: 1996 ident: 2024020318340624200_jbmr1985-bib-0012 article-title: Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis publication-title: J Bone Miner Res. doi: 10.1002/jbmr.5650110716 contributor: fullname: Genant – volume: 19 start-page: 429 year: 2004 ident: 2024020318340624200_jbmr1985-bib-0002 article-title: FGF-23 is a potent regulator of vitamin D metabolism and phosphonate homeostasis publication-title: J Bone Miner Res. doi: 10.1359/JBMR.0301264 contributor: fullname: Shimada – volume: 367 start-page: 20 issue: 1 year: 2012 ident: 2024020318340624200_jbmr1985-bib-0017 article-title: Levey AS; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C publication-title: N Engl J Med. doi: 10.1056/NEJMoa1114248 contributor: fullname: Inker – volume: 51 start-page: 395 year: 2008 ident: 2024020318340624200_jbmr1985-bib-0016 article-title: Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD publication-title: Am J Kidney Dis. doi: 10.1053/j.ajkd.2007.11.018 contributor: fullname: Stevens – volume: 295 start-page: E254 issue: 2 year: 2008 ident: 2024020318340624200_jbmr1985-bib-0026 article-title: Pathogenic role of Fgf23 in Dmp1-null mice publication-title: Am J Physiol Endocrinol Metab. doi: 10.1152/ajpendo.90201.2008 contributor: fullname: Liu – volume: 78 start-page: 679 year: 2010 ident: 2024020318340624200_jbmr1985-bib-0019 article-title: FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease publication-title: Kidney Int. doi: 10.1038/ki.2010.194 contributor: fullname: Yilmaz – volume: 23 start-page: 939 issue: 6 year: 2008 ident: 2024020318340624200_jbmr1985-bib-0023 article-title: Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro publication-title: J Bone Miner Res. doi: 10.1359/jbmr.080220 contributor: fullname: Wang – volume: 73 start-page: 1 year: 1986 ident: 2024020318340624200_jbmr1985-bib-0010 article-title: A case-control design for epidemiologic cohort studies and disease prevention trials publication-title: Biometricka. doi: 10.1093/biomet/73.1.1 contributor: fullname: Prentice – volume: 79 start-page: 1370 issue: 12 year: 2011 ident: 2024020318340624200_jbmr1985-bib-0022 article-title: Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease publication-title: Kidney Int. doi: 10.1038/ki.2011.47 contributor: fullname: Isakova – volume: 26 start-page: 857 year: 2011 ident: 2024020318340624200_jbmr1985-bib-0003 article-title: Serum fibroblast growth factor-23 (FFGF-23) and fracture risk in elderly men publication-title: J Bone Miner Res. doi: 10.1002/jbmr.263 contributor: fullname: Mirza – volume: 28 start-page: 563 issue: 4 year: 2013 ident: 2024020318340624200_jbmr1985-bib-0005 article-title: FGF23 production by osteocytes publication-title: Pediatr Nephrol. doi: 10.1007/s00467-012-2309-3 contributor: fullname: Bonewald – volume: 27 start-page: 1141 issue: 9 year: 2009 ident: 2024020318340624200_jbmr1985-bib-0028 article-title: FGF23 is a putative marker for bone healing and regeneration publication-title: J Orthop Res. doi: 10.1002/jor.20857 contributor: fullname: Goebel – volume: 67 start-page: 1120 year: 2005 ident: 2024020318340624200_jbmr1985-bib-0031 article-title: Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients publication-title: Kidney Int. doi: 10.1111/j.1523-1755.2005.00178.x contributor: fullname: Kazama – volume: 9 start-page: 336 year: 2005 ident: 2024020318340624200_jbmr1985-bib-0032 article-title: Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients publication-title: Ther Apher Dial. doi: 10.1111/j.1744-9987.2005.00293.x contributor: fullname: Koiwa – volume: 59 start-page: 233 year: 2011 ident: 2024020318340624200_jbmr1985-bib-0021 article-title: Mortality risk in older men associated with changes in weight, lean mass, and fat mass publication-title: J Am Geriatr Soc. doi: 10.1111/j.1532-5415.2010.03245.x contributor: fullname: Lee – volume: 145 start-page: 3087 year: 2004 ident: 2024020318340624200_jbmr1985-bib-0007 article-title: Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha I collagen promoter exhibit growth retardation, osteomalacia and disturbed phosphate homeostasis publication-title: Endocrinology. doi: 10.1210/en.2003-1768 contributor: fullname: Larsson – volume: 281 start-page: 6120 issue: 10 year: 2006 ident: 2024020318340624200_jbmr1985-bib-0027 article-title: Regulation of fibroblast growth factor-23 signaling by klotho publication-title: J Biol Chem. doi: 10.1074/jbc.C500457200 contributor: fullname: Kurosu – volume: 69 start-page: 341 year: 2007 ident: 2024020318340624200_jbmr1985-bib-0001 article-title: Phosphatonins and the regulation of phosphate homeostasis publication-title: Annu Rev Physiolo. doi: 10.1146/annurev.physiol.69.040705.141729 contributor: fullname: Berndt – volume: 18 start-page: 1227 issue: 7 year: 2003 ident: 2024020318340624200_jbmr1985-bib-0018 article-title: Serum FGF23 levels in normal and disordered phosphorus homeostasis publication-title: J Bone Miner Res. doi: 10.1359/jbmr.2003.18.7.1227 contributor: fullname: Weber – volume: 58 start-page: 682 year: 2011 ident: 2024020318340624200_jbmr1985-bib-0015 article-title: Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values publication-title: Am J Kidney Dis. doi: 10.1053/j.ajkd.2011.05.019 contributor: fullname: Inker – volume: 26 start-page: 557 issue: 5 year: 2005 ident: 2024020318340624200_jbmr1985-bib-0009 article-title: Overview of recruitment for the osteoporotic fractures in men study (MrOS) publication-title: Contemp Clin Trials. doi: 10.1016/j.cct.2005.05.005 contributor: fullname: Blank – volume: 303 start-page: F431 issue: 3 year: 2012 ident: 2024020318340624200_jbmr1985-bib-0029 article-title: Metabolic acisois increase fibroblast growth factor 23 in neomatula mouse bone publication-title: Am J Physiol Renal Physiol. doi: 10.1152/ajprenal.00199.2012 contributor: fullname: Krieger – volume: 28 start-page: 899 issue: 4 year: 2012 ident: 2024020318340624200_jbmr1985-bib-0030 article-title: Pharmacological inhibition of FGFR signaling ameliorates FGF23-mediated hypophosphatemic rickets publication-title: J Bone Miner Res. doi: 10.1002/jbmr.1810 contributor: fullname: Wšhrle – volume: 94 start-page: 2773 year: 2009 ident: 2024020318340624200_jbmr1985-bib-0020 article-title: Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2008-2786 contributor: fullname: Ensrud – volume: 18 start-page: 1227 issue: 7 year: 2003 ident: 2024020318340624200_jbmr1985-bib-0025 article-title: Serum FGF23 levels in normal and disordered phosphorus homeostasis publication-title: J Bone Miner Res. doi: 10.1359/jbmr.2003.18.7.1227 contributor: fullname: Weber – volume: 58 start-page: 381 issue: 6 year: 2009 ident: 2024020318340624200_jbmr1985-bib-0024 article-title: FGF23 is mainly synthesized by osteocytes in the regularly distributed osteocytic lacunar canalicular system established after physiological bone remodeling publication-title: J Electron Microsc (Tokyo). doi: 10.1093/jmicro/dfp032 contributor: fullname: Ubaidus – start-page: 169 volume-title: Osteoporosis year: 2007 ident: 2024020318340624200_jbmr1985-bib-0006 contributor: fullname: Bonewald – volume: 26 start-page: 569 issue: 5 year: 2005 ident: 2024020318340624200_jbmr1985-bib-0008 article-title: Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study—a large observational study of the determinants of fracture in older men publication-title: Contemp Clin Trials. doi: 10.1016/j.cct.2005.05.006 contributor: fullname: Orwoll – volume: 91 start-page: 3055 issue: 8 year: 2006 ident: 2024020318340624200_jbmr1985-bib-0013 article-title: C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2006-0710 contributor: fullname: Singh – volume: 59 start-page: 1 issue: 1 year: 1999 ident: 2024020318340624200_jbmr1985-bib-0014 article-title: Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System publication-title: Scand J Clin Lab Invest. doi: 10.1080/00365519950185940 contributor: fullname: Erlandsen – volume: 22 start-page: 211 issue: 2 year: 2007 ident: 2024020318340624200_jbmr1985-bib-0011 article-title: Predictors of nonspine fracture in elderly men: the MrOS study publication-title: J Bone Miner Res. doi: 10.1359/jbmr.061017 contributor: fullname: Lewis – volume: 38 start-page: 1310 year: 2006 ident: 2024020318340624200_jbmr1985-bib-0004 article-title: Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism publication-title: Nat Genet. doi: 10.1038/ng1905 contributor: fullname: Feng |
SSID | ssj0006566 |
Score | 2.386557 |
Snippet | ABSTRACT
Normal mineral metabolism is critical for skeletal integrity, and recently serum fibroblast growth factor 23 (FGF23) levels were found to be directly... Normal mineral metabolism is critical for skeletal integrity, and recently serum fibroblast growth factor 23 (FGF23) levels were found to be directly related... Normal mineral metabolism is critical for skeletal integrity and recently serum fibroblast Growth factor 23 (FGF23) levels were found to be directly related to... |
SourceID | pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 2325 |
SubjectTerms | Aged Demography FGF23 Fibroblast Growth Factors - blood Glomerular Filtration Rate Humans Incidence Kidney - physiopathology Male MEN OSTEOPOROSIS Osteoporotic Fractures - blood Osteoporotic Fractures - epidemiology Osteoporotic Fractures - physiopathology Risk Factors |
Title | Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: The Osteoporotic Fractures in Men (MrOS) study |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjbmr.1985 https://www.ncbi.nlm.nih.gov/pubmed/23677793 https://www.proquest.com/docview/1442743834 https://search.proquest.com/docview/1443999327 https://search.proquest.com/docview/1464507526 https://pubmed.ncbi.nlm.nih.gov/PMC3805817 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF5BT1ygDx4upRoQQunB1N6HnYVTgZqqUlpEQOJmrbO7FKTYVRIf-A_8aGbWiUlUgZC4WJY9ljfeb2a_2ex8y9hzoxM1tNrHlc59LCcZj43gkzhPvE2FTREjVJx8Ns4vvgzfnZJMzutVLUynD9FPuJFnhHhNDm6q-fFv0dDv1XT2ElNmKjDHLCGUb4gPfRQmntIxSFpoIdKVqlDCj_snN8eiGwTz5jrJdf4aBqDi3n81fZvdXfJOOOmAssNuuXqX7Z3UmHNPf8ALCCtBwxT7Hvu51mfQeECUtlPw-MqmQrK9gK-Yuy-uoNurB7iAQfG-4OIITG2BJu-p-hc8FWC1mM7jJWhoN3CYuvoVIDLhEsHVIPVvsDlQrBuOXA2D0exyfARB-vY--1ycfnp7Fi93bYgnCgNAXCntkUZYJYXhqa3wwNNMcy-9zzIujdfC5jIxSmvkTrn36QTjDFINJ51SRjxgW3VTu0cMLMJcGC1wHOfSphVSOafwAWG9S4xTEXu26r_yuhPnKDsZZl7SNy7pG0fsYNWz5dI_55jwSEzHMTuXEXva30bPor9LTO2aNtgge0N-m__NJpPIqBXPIvawA0vfEtLGyzH8RSzfgFFvQMrem3fqb1dB4VsM0YNSfO8gwOjPP648fzP6SCf7_276mN3htKdHKKg8YFuLWeuesNtz2x4GF8Lj-PziFwGzIYY |
link.rule.ids | 230,315,782,786,887,1408,27933,27934,46064,46488 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoOcCFV3kECgwIoe0hNPEj2SAuBRoW6LaIFolb5KxtCtI6aLs58B_40cw4u2FXFQiJS7RKJoo3_mb8jeP5zNgTXSRqaAoX10XuYjnJeKwFn8R54kwqTIoYoeLk0XF--Hn4ep9kcl4sa2E6fYh-wo08I8RrcnCakN79rRr6rZ7OnmHOrDbYRZkhEKmAQ3zo4zAxlY5D0lILkS51hRK-29-6Phqdo5jnV0quMtgwBJVX_6_x19iVBfWEvQ4r19kF62-wrT2Paff0BzyFsBg0zLJvsZ8r3QaNAwRqOwWHz2xq5Ntz-ILp-_wUuu16gAsYlG9KLnZAewM0f08FwOCoBqvFjB5PQUMbgsPU-ueA4IQjxFeD7L_B5kC5aji2Hgbj2dHxDgT125vsU7l_8moULzZuiCcKY0Bcq8IhkzBKCs1TU-OBp1nBnXQuy7jUrhAml4lWRYH0KXcunWCoQbZhpVVKi1ts0zfe3mFgEOlCFwKHci5NWiObswpvEMbZRFsVscfLDqy-d_ocVafEzCt6xxW944htL7u2WrjoGeY8EjNyTNBlxB71l9G56IuJ9rZpgw0SOKS4-d9sMomkWvEsYrc7tPQtIXm8HCNgxPI1HPUGJO69fsV_PQ0i32KITpTicwcBR3_-c9W7l-OP9OPuv5s-ZJdGJ-OD6uDt4ft77DKnLT5CfeU225zPWnufbZyZ9kHwp19TLSSi |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RIiEuvMojUGBACG0PoYkfyRpOhTaUx7YVLRK3yFnbFKRNqu3mwH_gRzN2dsOuKhASl2iVTBRv_M34G8fzGeCZVokcGuXiSuUuFuOMxZqzcZwnzqTcpIQRX5y8f5wffBnu7nmZnFeLWphOH6KfcPOeEeK1d_Az47Z_i4Z-rybTF5QyyzW4LIiGe-F8zo_6MOyJSkch_UoLni5khRK23d-6OhhdYJgXF0ouE9gwAhXX_6vtN-DanHjiToeUm3DJ1rdgY6empHvyA59jWAoa5tg34OdSp2HjkGDaTtDRI5uK2PYMv1LyPjvFbrMeZBwHxduC8S3UtUE_e-_Lf9H5CqyW8nk6hY3fDhwntn6JBE08JHQ1xP0bag4Wy4YjW-NgND083sKgfXsbPhd7J2_24_m2DfFYUgSIK6kc8QgjBdcsNRUdWJop5oRzWcaEdoqbXCRaKkXkKXcuHVOgIa5hhZVS8zuwXje1vQdoCOdcK04DORMmrYjLWUk3cONsoq2M4Omi_8qzTp2j7HSYWenfcenfcQSbi54t5w56ThmPoHyc0nMRwZP-MrmW_16ia9u0wYboGxHc_G82mSBKLVkWwd0OLH1LvDheTvEvgnwFRr2Bl_ZevVJ_Ow0S33xILpTScwcBRn_-c-X716NP_sf9fzd9DFeOdovy47uDDw_gKvP7e4Tiyk1Yn01b-xDWzk37KHjTL7B7I0g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+serum+fibroblast+growth+factor+23+%28FGF23%29+and+incident+fractures+in+older+men%3A+The+Osteoporotic+Fractures+in+Men+%28MrOS%29+study&rft.jtitle=Journal+of+bone+and+mineral+research&rft.au=Lane%2C+Nancy+E&rft.au=Parimi%2C+Neeta&rft.au=Corr%2C+Maripat&rft.au=Yao%2C+Wei&rft.date=2013-11-01&rft.issn=0884-0431&rft.eissn=1523-4681&rft.volume=28&rft.issue=11&rft.spage=2325&rft.epage=2332&rft_id=info:doi/10.1002%2Fjbmr.1985&rft.externalDBID=10.1002%252Fjbmr.1985&rft.externalDocID=JBMR1985 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0884-0431&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0884-0431&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0884-0431&client=summon |